Average bioequivalence of single 500 mg doses of two oral formulations of levofloxacin: a randomized, open-label, two-period crossover study in healthy adult Brazilian volunteers . Braz. J. Pharm. Sci. [Internet]. 2015 Mar. 1 [cited 2024 Jul. 24];51(1):203-11. Available from: https://revistas.usp.br/bjps/article/view/100513